Expanding the Frontiers of Pharmacy Practice (II)
Kristin Wiisanen, PharmD - Clinical Professor and Director of the Graduate Program in Precision Medicine at the University of Florida College of Pharmacy - talks with us about using genomics to guide therapeutic decisions.\nKey Lessons:\nPrecision medicine and personalized medicine are synonymous terms.\nPharmacogenomics is a tool to personalize treatment decisions.\xa0 However, it is not the only tool.\xa0 Other readily available and routinely collected clinical information has been used to personalize therapy for decades (e.g. blood type, serum creatinine, CV risk score).\nWhile creating a separate pharmacogenomic service can help ease practitioners into using pharmacogenomic tests, learning how to integrate genetic information as a routine part of clinical decision-making is the ultimate goal.\nPharmacists have a unique role (and responsibility) to know when and how to use the results of pharmacogenomic tests.\nTeaching students, residents, and fellows to use pharmacogenomic information should be done in an integrated manner - considered alongside other clinical data, not in isolation.\nSeveral excellent resources now exist that can assist pharmacists and other providers use the results of pharmacogenomic tests including the Pharmacogenomics Knowledge Base (PharmGKB) and the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines.